topic

Immunogenicity in humans of a transdermal multipeptide melanoma vaccine administered with or without a TLR7 agonist
Max O Meneveau, Gina R Petroni, Elise P Salerno, Kevin T Lynch, Mark Smolkin, Elizabeth Woodson, Kimberly A Chianese-Bullock, Walter C Olson, Donna Deacon, James W Patterson, William W Grosh, Craig L Slingluff

Journal for ImmunoTherapy of Cancer May 2021, 9 (5) e002214; DOI: 10.1136/jitc-2020-002214
Immune profiling of COVID-19: preliminary findings and implications for the pandemic
Holden T Maecker

Journal for ImmunoTherapy of Cancer May 2021, 9 (5) e002550; DOI: 10.1136/jitc-2021-002550
Shared inflammatory pathways and therapeutic strategies in COVID-19 and cancer immunotherapy
Lorenzo Iovino, Laurel A Thur, Sacha Gnjatic, Aude Chapuis, Filippo Milano, Joshua A Hill

Journal for ImmunoTherapy of Cancer May 2021, 9 (5) e002392; DOI: 10.1136/jitc-2021-002392
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies
Daniela GM Tantalo, Amanda J Oliver, Bianca von Scheidt, Aaron J Harrison, Scott N Mueller, Michael H Kershaw, Clare Y Slaney

Journal for ImmunoTherapy of Cancer May 2021, 9 (5) e002555; DOI: 10.1136/jitc-2021-002555
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management
Jarushka Naidoo, Joshua E Reuss, Karthik Suresh, David Feller-Kopman, Patrick M Forde, Seema Mehta Steinke, Clare Rock, Douglas B Johnson, Mizuki Nishino, Julie R Brahmer

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000984; DOI: 10.1136/jitc-2020-000984
NF-κB p50-deficient immature myeloid cell (p50-IMC) adoptive transfer slows the growth of murine prostate and pancreatic ductal carcinoma
Rahul Suresh, David J Barakat, Theresa Barberi, Lei Zheng, Elizabeth Jaffee, Kenneth J Pienta, Alan D Friedman

Journal for ImmunoTherapy of Cancer Jan 2020, 8 (1) e000244; DOI: 10.1136/jitc-2019-000244
Biomarkers for immunotherapy for treatment of glioblastoma
John P Lynes, Anthony K Nwankwo, Hannah P Sur, Victoria E Sanchez, Kwadwo A Sarpong, Oluwatobi I Ariyo, Gifty A Dominah, Edjah K Nduom

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000348; DOI: 10.1136/jitc-2019-000348
Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine
Claire Smalley Rumfield, Samuel T Pellom, Y Maurice Morillon II, Jeffrey Schlom, Caroline Jochems

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000612; DOI: 10.1136/jitc-2020-000612
Management of hepatitis B in the era of checkpoint inhibition
Janice Dutcher

Journal for ImmunoTherapy of Cancer Feb 2020, 8 (1) e000276; DOI: 10.1136/jitc-2019-000276
Nanopore sequencing as a scalable, cost-effective platform for analyzing polyclonal vector integration sites following clinical T cell therapy
Ping Zhang, Devika Ganesamoorthy, Son Hoang Nguyen, Raymond Au, Lachlan J Coin, Siok-Keen Tey

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000299; DOI: 10.1136/jitc-2019-000299

Main menu

topic

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

topic

Pages